—

NEXTBio Capital Management LP

Q1 2026 13F Holdings

  • Location
    austin, TX
  • Num holdings

    24

  • Value ($000)

    $215,370

  • Date Filed
    05/14/2026
  • Form type
    13F-HR
  • CIK
    0002038158
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
T
TERN

TERNS PHARMACEUTICALS INC

COM
880881107
$31.87M
15 %

604,534

P
PTGX

PROTAGONIST THERAPEUTICS INC

COM
74366E102
$24.2M
11 %

229,619

S
STTK

SHATTUCK LABS INC

COM
82024L103
$20.25M
9 %

3,149,907

---

VOR BIOPHARMA INC

COM NEW
929033207
$17.84M
8 %

999,967

C
CMPS

COMPASS PATHWAYS PLC

SPONSORED ADS
20451W101
$11.18M
5 %

2,021,407

R
RYTM

RHYTHM PHARMACEUTICALS INC

COM
76243J105
$10.97M
5 %

126,078

---

XENON PHARMACEUTICALS INC

COM
98420N105
$10.65M
5 %

183,225

---

PALVELLA THERAPEUTICS INC NE

COM
697947109
$10.31M
5 %

82,686

---

ZENAS BIOPHARMA INC

COM
98937L105
$8.34M
4 %

426,736

I
IVA

INVENTIVA SA

ADS
46124U107
$7.4M
3 %

1,333,484

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 24